FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30252711000001105: Daylette 0.02mg/3mg tablets (Consilient Health Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93992101000001113 Daylette 0.02mg/3mg tablets (Consilient Health Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93992201000001118 Daylette 0.02mg/3mg tablets (Consilient Health Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Is a Ethinylestradiol 20microgram / Drospirenone 3mg tablets true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has specific active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Is a Daylette true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) 84 tablet 3 x 28 tablets Has AMP True Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start